These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 11437849)

  • 1. Hearing evaluation with distortion-product otoacoustic emissions in young patients undergoing haemodialysis.
    Stavroulaki P; Nikolopoulos TP; Psarommatis I; Apostolopoulos N
    Clin Otolaryngol Allied Sci; 2001 Jun; 26(3):235-42. PubMed ID: 11437849
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of hemodialysis on hearing using pure-tone audiometry and distortion-product otoacoustic emissions.
    Ozturan O; Lam S
    ORL J Otorhinolaryngol Relat Spec; 1998; 60(6):306-13. PubMed ID: 9742277
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effect of inner ear hearing loss on delayed otoacoustic emissions (TEOAE) and distortion products (DPOAE)].
    Hoth S
    Laryngorhinootologie; 1996 Dec; 75(12):709-18. PubMed ID: 9081275
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased prevalence of early cochlear damage in young patients with type 1 diabetes detected by distortion product otoacoustic emissions.
    Botelho CT; Carvalho SA; Silva IN
    Int J Audiol; 2014 Jun; 53(6):402-8. PubMed ID: 24564623
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factors affecting sensitivity of distortion-product otoacoustic emissions to ototoxic hearing loss.
    Reavis KM; Phillips DS; Fausti SA; Gordon JS; Helt WJ; Wilmington D; Bratt GW; Konrad-Martin D
    Ear Hear; 2008 Dec; 29(6):875-93. PubMed ID: 18753950
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cochlear sensitivity in children with chronic kidney disease and end-stage renal disease undergoing hemodialysis.
    Renda R; Renda L; Selçuk ÖT; Eyigör H; Yılmaz MD; Osma Ü
    Int J Pediatr Otorhinolaryngol; 2015 Dec; 79(12):2378-83. PubMed ID: 26590002
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deterioration in Distortion Product Otoacoustic Emissions in Auditory Neuropathy Patients With Distinct Clinical and Genetic Backgrounds.
    Kitao K; Mutai H; Namba K; Morimoto N; Nakano A; Arimoto Y; Sugiuchi T; Masuda S; Okamoto Y; Morita N; Sakamoto H; Shintani T; Fukuda S; Kaga K; Matsunaga T
    Ear Hear; 2019; 40(1):184-191. PubMed ID: 29688962
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pure-tone threshold estimation from extrapolated distortion product otoacoustic emission I/O-functions in normal and cochlear hearing loss ears.
    Boege P; Janssen T
    J Acoust Soc Am; 2002 Apr; 111(4):1810-8. PubMed ID: 12002865
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distortion-product otoacoustic emissions and cochlear microphonics: relationships in patients with and without endolymphatic hydrops.
    Fetterman BL
    Laryngoscope; 2001 Jun; 111(6):946-54. PubMed ID: 11404602
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distortion product otoacoustic emissions in an industrial setting.
    Korres GS; Balatsouras DG; Tzagaroulakis A; Kandiloros D; Ferekidou E; Korres S
    Noise Health; 2009; 11(43):103-10. PubMed ID: 19414930
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Input-output functions of the nonlinear-distortion component of distortion-product otoacoustic emissions in normal and hearing-impaired human ears.
    Zelle D; Lorenz L; Thiericke JP; Gummer AW; Dalhoff E
    J Acoust Soc Am; 2017 May; 141(5):3203. PubMed ID: 28599560
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Distortion product of otoacoustic emissions in normal hearing and sensorineural hearing loss].
    Schlögel H; Stephan K; Böheim K; Welzl-Müller K
    HNO; 1995 Jan; 43(1):19-24. PubMed ID: 7890546
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Measuring and analyzing of otoacoustic emission tests of a family with genetic progressive sensorineural hearing loss].
    Yu H; Ke XM; Yu DL; Li Q; Liu YH; Ding GY
    Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2000 Apr; 14(4):157-9. PubMed ID: 12541488
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An objective method of analyzing cochlear versus noncochlear patterns of distortion-product otoacoustic emissions in patients with acoustic neuromas.
    Telischi F
    Laryngoscope; 2000 Apr; 110(4):553-62. PubMed ID: 10763999
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distortion product otoacoustic emissions as a prognostic factor for idiopathic sudden sensorineural hearing loss.
    Chao TK; Chen TH
    Audiol Neurootol; 2006; 11(5):331-8. PubMed ID: 16983184
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transiently evoked and distortion-product otoacoustic emissions. Comparison of results from normally hearing and hearing-impaired human ears.
    Probst R; Harris FP
    Arch Otolaryngol Head Neck Surg; 1993 Aug; 119(8):858-60. PubMed ID: 8343248
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-frequency hearing influences lower-frequency distortion-product otoacoustic emissions.
    Arnold DJ; Lonsbury-Martin BL; Martin GK
    Arch Otolaryngol Head Neck Surg; 1999 Feb; 125(2):215-22. PubMed ID: 10037289
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Short-term changes of hearing and distortion product otoacoustic emissions in sudden sensorineural hearing loss.
    Park H; Lee Y; Park M; Kim J; Na B; Shin J
    Otol Neurotol; 2010 Aug; 31(6):862-6. PubMed ID: 20601916
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of cochlear hearing disorders: normative distortion product otoacoustic emission measurements.
    Mills DM; Feeney MP; Gates GA
    Ear Hear; 2007 Dec; 28(6):778-92. PubMed ID: 17982366
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Otoacoustic emissions measurements in children during the chemotherapy because of the acute lymphoblastic leukemia].
    Lisowska G; Namysłowski G; Hajduk A; Polok A; Tomaszewska R; Misiołek M
    Otolaryngol Pol; 2006; 60(3):415-20. PubMed ID: 16989457
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.